Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 2-Amino-5-bromopyridine | HCID 70622 | — |
| Reactant | HCID 57899417 | HCID 57899417 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 57899381 | HCID 57899381 | — |
Reaction Steps
A solution of 1-(4-chloro-phenyl)-9-(3-methanesulfonyl-phenyl)-2-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1,9-dihydro-purin-6-one (prepared as described in example 38, 0.300 g, 0.497 mmol) in N,N-dimethylformamide (20 mL) is degassed with argon for 0.5 h. Then 2-amino-5-bromopyridine (0.129 g, 0.746 mmol), cesium carbonate (0.324 g, 0.995 mmol), Pd(dppf)2Cl2 (0.036 g, 0.049 mmol) is added and the resulted mixture is degassed with argon for 0.5 h. The reaction mixture is then heated at 100° C. for 6 h. The reaction mixture is cooled to rt and diluted with water and extracted with ethyl acetate (3×). The combined organic layer is washed with brine, dried over Na2SO4, concentrated, and purified by column chromatography to afford 2-[4-(6-amino-pyridin-3-yl)-phenyl]-1-(4-chloro-phenyl)-9-(3-methanesulfonyl-phenyl)-1,9-dihydro-purin-6-one. 1H NMR (DMSO-d6, 400 MHz) δ 8.77 (br, 1H), 8.45 (m, 1H), 8.30 (m, 1H), 8.23-8.27 (m, 2H), 8.13 (br, 1H), 8.04 (d, 1H), 7.90 (t, 1H), 7.55 (m, 2H), 7.41-7.53 (m, 5H), 7.01 (d, 1H), 3.30 (s, 3H); LC-MS calculated for C29H21ClN6O3S (M+H+) 569.1, found 569.2.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08722691B2 |
|---|
| Source dataset | uspto-grants-2014_05 |
|---|
| ORD ID | ord-fec379b3fd58434fbaf77d6e55ca8c2c |
|---|
| Source note | uspto-grants-2014_05 |
|---|